Novimmune grants Tiziana an exclusive license to NI-1201, an anti-IL-6R monoclonal antibody for the treatment of autoimmune and inflammatory diseases - WuXi XPress: for WuXi news and R&D insights
Damir Očko | Study on Shievering no 3 - 2 (2013) | Artsy